188 results
8-K
EX-99.1
INVA
Innoviva Inc
29 Feb 24
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
4:15pm
In November 2023, in collaboration with The Global Antibiotic Research & Development Partnership (GARDP), Innoviva announced that zoliflodacin, a first … adjustments)
Cost of license revenue
Selling, general and administrative
Research and development
Amortization of acquired intangible assets
Gain on TRC
8-K
EX-99.1
t398i6bjz8 cbnzq
1 Nov 23
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:30pm
8-K
EX-10.1
6n5hpt4n2qd ok
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
ikbvp jwv1g0mh4hxxh
2 Aug 23
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
d5u94173 jjf2k1c8
24 May 23
Corporate Presentation May 2023
5:18pm
8-K
EX-99.1
fxprd77chkvm1my5hiyy
9 May 23
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent
5:21pm
8-K
EX-99.1
1yneyl 1m
9 Nov 22
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
4:17pm
8-K/A
EX-99.1
x76ehiytvim8s c1mn
28 Oct 22
Completion of Acquisition or Disposition of Assets
4:22pm
8-K
EX-99.1
32844c 7t
23 Aug 22
Other Events
4:08pm
8-K
EX-99.1
7upb4lw6it7st1 1q
27 Jul 22
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
4:16pm
SC TO-T
EX-99
hf3oliq
25 Jul 22
Third party tender offer statement
8:34am
SC TO-C
EX-2.1
9bh5li
23 May 22
Information about tender offer
8:53pm